diaendoСахарный диабетDiabetes mellitus2072-03512072-0378Endocrinology research centre10.14341/DM12972diaendo-12972Research ArticleОбзорыReviewОсобенности ведения пациентов с сахарным диабетом во время месяца РамаданManagement of diabetes during Ramadan: an update for Russian-speaking doctorshttps://orcid.org/0000-0002-4218-4456Эль-ТаравиЯ.А.El-TaraviY.A.

Эль-Тарави Ясмин Ахмед Али; Researcher ID: GNW-6289-2022; Scopus Author ID: 57222549640.

119992, Москва, ул. Трубецкая, д. 8, стр. 2

Yasmin A. El-Taravi; Researcher ID: GNW-6289-2022; Scopus Author ID: 57222549640.

8-2 Trubetskaya street, 119991 Moscow

yasmineltaravi@gmail.comhttps://orcid.org/0000-0002-5518-9301БаймухамбетоваД. В.BaimukhambetovaD. V.

Баймухамбетова Дина Владимировна

Москва

Dina V. Baimukhambetova

Moscow

dbaimukhambietova@bk.ruhttps://orcid.org/0000-0002-9885-7672ГорленкоК. Л.GorlenkoC. L.

Горленко Кирилл Леонидович

Москва

Cyrill L. Gorlenko

Moscow

mr.gorlenko@mail.ruhttps://orcid.org/0000-0003-4249-3053КиселевГ. Ю.KiseljowH. Yu.

Киселев Герман Юрьевич

Москва

Herman Yu. Kiselev

Moscow

kiselev32rus@gmail.comhttps://orcid.org/0000-0003-0716-0923КохановскаяЯ. Ю.KokhanovskaiaI. Iu.

Кохановская Яна Юрьевна

Москва

Iana Iu. Kokhanovskaia

Moscow

ikoncoderm@gmail.comhttps://orcid.org/0000-0001-6009-7586БуторинаА. И.BurotinaA. I.

Буторина Анастасия Игоревна

Москва

Anastasia I. Butorina

Moscow

asyalindt@gmail.comhttps://orcid.org/0000-0002-3593-4079РассадинаЭ. С.RassadinaE. S.

Рассадина Эмилия Сергеевна

Москва

Emiliya S. Rassadina

Moscow

emiliarassadina23587@gmail.comhttps://orcid.org/0000-0002-0202-1257МартиросянН. С.MartirosianN. S.

Мартиросян Нарине Степановна - кандидат медицинских наук, доцент.

Москва

Narine S. Martirosian - MD, PhD, Associate Professor. Scopus Author ID: 6603436552.

Moscow

narinarine@list.ruhttps://orcid.org/0000-0001-9390-1200ПетунинаН. А.PetuninaN. A.

Петунина Нина Александровна - доктор медицинских наук, профессор, член-корр. РАН. Scopus Author ID: 6603436552.

Москва

Nina A. Petunina - MD, PhD, Professor.

Moscow

napetunina@mail.ruПервый Московский государственный медицинский университет им. И.М. Сеченова (Сеченовский Университет)РоссияI.M. Sechenov First Moscow State Medical University (Sechenov University)Russian FederationПервый Московский государственный медицинский университет им. И.М. Сеченова (Сеченовский Университет); Городская клиническая больница №67 им. Л.А. ВорохобоваРоссияI.M. Sechenov First Moscow State Medical University (Sechenov University); L.A. Vorokhobov City Clinical Hospital No. 67Russian Federation2023100220232618292Copyright © Эль-Тарави Я., Баймухамбетова Д.В., Горленко К.Л., Киселев Г.Ю., Кохановская Я.Ю., Буторина А.И., Рассадина Э.С., Мартиросян Н.С., Петунина Н.А., 20232023Эль-Тарави Я., Баймухамбетова Д.В., Горленко К.Л., Киселев Г.Ю., Кохановская Я.Ю., Буторина А.И., Рассадина Э.С., Мартиросян Н.С., Петунина Н.А.El-Taravi Y., Baimukhambetova D.V., Gorlenko C.L., Kiseljow H.Y., Kokhanovskaia I.I., Burotina A.I., Rassadina E.S., Martirosian N.S., Petunina N.A.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://www.dia-endojournals.ru/jour/article/view/12972

Пост во время месяца Рамадан — один из пяти столпов ислама — является обязательным для всех здоровых мусульман с возраста половой зрелости. Несмотря на то что религия разрешает людям с серьезными заболеваниями не соблюдать пост, многие мусульмане с сахарным диабетом (СД) все равно постятся из года в год. Учитывая, что мусульмане — вторая по численности религиозная конфессия в России, крайне важно точно понимать, какой тактики лучше придерживаться при клиническом сопровождении постящихся пациентов с СД 1 и 2 типов во время месяца Рамадан. В данной обзорной статье рассмотрены основные физиологические и патофизиологические изменения в метаболизме пациентов с СД в течение всего месяца Рамадан, ключевые аспекты ведения таких групп пациентов, даны рекомендации по обучению пациентов грамотному ведению своего заболевания, информация о том, как часто необходимо измерять гликемию в течение суток и в какой момент необходимо прервать пост. Также обсуждаются конкретные рекомендации по особенностям питания, физической нагрузке, необходимости коррекции медикаментозной терапии в течение всего месяца соблюдения поста.

Fasting during the Islamic Ramadan month is one of the five obligatory pillars for each adult, healthy, and sane Muslim. People with severe illnesses, including type 1 and type 2 diabetes mellitus are exempt from fasting. However, many Muslims often insist on Ramadan participating despite any medical advises. It’s known that Muslims are the second largest religious group in Russia; thus, its crucial to have as much modern recommendation for management patients with type 1 and type 2 diabetes mellitus as possible. The aim of this narrative review is to evaluate physiological and pathophysiological metabolism changing during holy Ramadan month, to clarify the management of patients with type 1 and type 2 diabetes mellitus during Ramadan, to determine the frequency of glucose measuring during the day, and to understand when its time to interrupt the fasting. Moreover, we discuss specific recommendations in glucose-lowering therapy changing, nutrition, physical activities and education.

сахарный диабет 1 типасахарный диабет 2 типаРамаданпостИфтарСухуробучение диабетуtype 1 diabetestype 2 diabetesRamadanIftaarSuhoorfastingdiabetes educationРабота выполнена по инициативе авторов без привлечения финансовых средствReferencesCho NH, Shaw JE, Karuranga S, et al. IDF Diabetes Atlas: Global estimates of diabetes prevalence for 2017 and projections for 2045. Diabetes Res Clin Pract. 2018;138:271-281. doi: https://doi.org/10.1016/j.diabres.2018.02.023Cho NH, Shaw JE, Karuranga S, et al. IDF Diabetes Atlas: Global estimates of diabetes prevalence for 2017 and projections for 2045. Diabetes Res Clin Pract. 2018;138:271-281. doi: https://doi.org/10.1016/j.diabres.2018.02.023Wikipedia [Internet]. Muslim population growth. 2022. [cited 06.05.2022]. Available from: https://en.wikipedia.org/w/index.php?title=Muslim_population_growth&oldid=1085822338Wikipedia [Internet]. Muslim population growth. 2022. [cited 06.05.2022]. Available from: https://en.wikipedia.org/w/index.php?title=Muslim_population_growth&oldid=1085822338Сколько мусульман в России. Количество приверженцев Ислама. Доступно по: https://medinaschool.org/library/obshestvo/istoriya-islama/skolko-musulman-v-rossii. Ссылка активна на 06.05.22.Skol’ko musul’man v Rossii. Kolichestvo priverzhentsev Islama. (In Russ.). Доступно по: https://medinaschool.org/library/obshestvo/istoriya-islama/skolko-musulman-v-rossii. Ссылка активна на 06.05.22.Википедия [Интернет]. Ислам в России. 2022. Доступно по: https://ru.wikipedia.org/w/index.php?title=%D0%98%D1%81%D0%BB%D0%B0%D0%BC_%D0%B2_%D0%A0%D0%BE%D1%81%D1%81%D0%B8%D0%B8&oldid=121556685. Ссылка активна на 06.05.22.Wikipedia [Internet]. Islam v Rossii. 2022. (In Russ.). Доступно по: https://ru.wikipedia.org/w/index.php?title=%D0%98%D1%81%D0%BB%D0%B0%D0%BC_%D0%B2_%D0%A0%D0%BE%D1%81%D1%81%D0%B8%D0%B8&oldid=121556685. Ссылка активна на 06.05.22.Bouchareb S, Chrifou R, Bourik Z, et al. “I am my own doctor”: A qualitative study of the perspectives and decision-making process of Muslims with diabetes on Ramadan fasting. Schouten B, ed. PLoS One. 2022;17(3):e0263088. doi: https://doi.org/10.1371/journal.pone.0263088Bouchareb S, Chrifou R, Bourik Z, et al. “I am my own doctor”: A qualitative study of the perspectives and decision-making process of Muslims with diabetes on Ramadan fasting. Schouten B, ed. PLoS One. 2022;17(3):e0263088. doi: https://doi.org/10.1371/journal.pone.0263088IDF Diabetes Atlas. [Интернет].Tenth Edition. [cited 04.05.2022]. Available from: https://diabetesatlas.org/IDF Diabetes Atlas. [Интернет].Tenth Edition. [cited 04.05.2022]. Available from: https://diabetesatlas.org/Salti I, Bénard E, Detournay B, et al. A population-based study of diabetes and its characteristics during the fasting month of Ramadan in 13 countries: results of the epidemiology of diabetes and Ramadan 1422/2001 (EPIDIAR) study. Diabetes Care. 2004;27(10):2306-2311. doi: https://doi.org/10.2337/diacare.27.10.2306Salti I, Bénard E, Detournay B, et al. A population-based study of diabetes and its characteristics during the fasting month of Ramadan in 13 countries: results of the epidemiology of diabetes and Ramadan 1422/2001 (EPIDIAR) study. Diabetes Care. 2004;27(10):2306-2311. doi: https://doi.org/10.2337/diacare.27.10.2306Babineaux SM, Toaima D, Boye KS, et al. Multi-country retrospective observational study of the management and outcomes of patients with Type 2 diabetes during Ramadan in 2010 (CREED). Diabet Med J Br Diabet Assoc. 2015;32(6):819-828. doi: https://doi.org/10.1111/dme.12685Babineaux SM, Toaima D, Boye KS, et al. Multi-country retrospective observational study of the management and outcomes of patients with Type 2 diabetes during Ramadan in 2010 (CREED). Diabet Med J Br Diabet Assoc. 2015;32(6):819-828. doi: https://doi.org/10.1111/dme.12685Al Awadi FF, Echtay A, Al Arouj M, et al. Patterns of Diabetes Care Among People with Type 1 Diabetes During Ramadan: An International Prospective Study (DAR-MENA T1DM). Adv Ther. 2020;37(4):1550-1563. doi: https://doi.org/10.1007/s12325-020-01267-4Al Awadi FF, Echtay A, Al Arouj M, et al. Patterns of Diabetes Care Among People with Type 1 Diabetes During Ramadan: An International Prospective Study (DAR-MENA T1DM). Adv Ther. 2020;37(4):1550-1563. doi: https://doi.org/10.1007/s12325-020-01267-4BaHammam A, Alrajeh M, Albabtain M, et al. Circadian pattern of sleep, energy expenditure, and body temperature of young healthy men during the intermittent fasting of Ramadan. Appetite. 2010;54(2):426-429. doi: https://doi.org/10.1016/j.appet.2010.01.011BaHammam A, Alrajeh M, Albabtain M, et al. Circadian pattern of sleep, energy expenditure, and body temperature of young healthy men during the intermittent fasting of Ramadan. Appetite. 2010;54(2):426-429. doi: https://doi.org/10.1016/j.appet.2010.01.011Roky R, Chapotot F, Hakkou F, et al. Sleep during Ramadan intermittent fasting. J Sleep Res. 2001;10(4):319-327. doi: https://doi.org/10.1046/j.1365-2869.2001.00269.xRoky R, Chapotot F, Hakkou F, et al. Sleep during Ramadan intermittent fasting. J Sleep Res. 2001;10(4):319-327. doi: https://doi.org/10.1046/j.1365-2869.2001.00269.xHaouari M, Haouari-Oukerro F, Sfaxi A, et al. How Ramadan fasting affects caloric consumption, body weight, and circadian evolution of cortisol serum levels in young, healthy male volunteers. Horm Metab Res. 2008;40(8):575-577. doi: https://doi.org/10.1055/s-2008-1065321Haouari M, Haouari-Oukerro F, Sfaxi A, et al. How Ramadan fasting affects caloric consumption, body weight, and circadian evolution of cortisol serum levels in young, healthy male volunteers. Horm Metab Res. 2008;40(8):575-577. doi: https://doi.org/10.1055/s-2008-1065321BaHammam AS, Almeneessier AS. Recent Evidence on the impact of Ramadan diurnal intermittent fasting, mealtime, and circadian rhythm on cardiometabolic risk: A review. Front Nutr. 2020;7(08):575-577. doi: https://doi.org/10.3389/fnut.2020.00028BaHammam AS, Almeneessier AS. Recent Evidence on the impact of Ramadan diurnal intermittent fasting, mealtime, and circadian rhythm on cardiometabolic risk: A review. Front Nutr. 2020;7(08):575-577. doi: https://doi.org/10.3389/fnut.2020.00028Al-Rawi N, Madkour M, Jahrami H, et al. Effect of diurnal intermittent fasting during Ramadan on ghrelin, leptin, melatonin, and cortisol levels among overweight and obese subjects: A prospective observational study. PloS One. 2020;15(8):e0237922. doi: https://doi.org/10.1371/journal.pone.0237922Al-Rawi N, Madkour M, Jahrami H, et al. Effect of diurnal intermittent fasting during Ramadan on ghrelin, leptin, melatonin, and cortisol levels among overweight and obese subjects: A prospective observational study. PloS One. 2020;15(8):e0237922. doi: https://doi.org/10.1371/journal.pone.0237922Bahijri S, Borai A, Ajabnoor G, et al. Relative metabolic stability, but disrupted circadian cortisol secretion during the fasting month of Ramadan. PloS One. 2013;8(4):e60917. doi: https://doi.org/10.1371/journal.pone.0060917Bahijri S, Borai A, Ajabnoor G, et al. Relative metabolic stability, but disrupted circadian cortisol secretion during the fasting month of Ramadan. PloS One. 2013;8(4):e60917. doi: https://doi.org/10.1371/journal.pone.0060917Shirreffs SM, Maughan RJ. Water and salt balance in young male football players in training during the holy month of Ramadan. J Sports Sci. 2008;26(S3):S47-54. doi: https://doi.org/10.1080/02640410802428097Shirreffs SM, Maughan RJ. Water and salt balance in young male football players in training during the holy month of Ramadan. J Sports Sci. 2008;26(S3):S47-54. doi: https://doi.org/10.1080/02640410802428097Leiper JB, Molla AM, Molla AM. Effects on health of fluid restriction during fasting in Ramadan. Eur J Clin Nutr. 2003;57(S2):S30-38. doi: https://doi.org/10.1038/sj.ejcn.1601899Leiper JB, Molla AM, Molla AM. Effects on health of fluid restriction during fasting in Ramadan. Eur J Clin Nutr. 2003;57(S2):S30-38. doi: https://doi.org/10.1038/sj.ejcn.1601899Ibrahim M, Abu Al Magd M, Annabi FA, et al. Recommendations for management of diabetes during Ramadan: update 2015. BMJ Open Diabetes Res Care. 2015;3(1):e000108. doi: https://doi.org/10.1136/bmjdrc-2015-000108Ibrahim M, Abu Al Magd M, Annabi FA, et al. Recommendations for management of diabetes during Ramadan: update 2015. BMJ Open Diabetes Res Care. 2015;3(1):e000108. doi: https://doi.org/10.1136/bmjdrc-2015-000108Finch GM, Day JE, Razak, et al. Appetite changes under free-living conditions during Ramadan fasting. Appetite. 1998;31(2):159-170. doi: https://doi.org/10.1006/appe.1998.0164Finch GM, Day JE, Razak, et al. Appetite changes under free-living conditions during Ramadan fasting. Appetite. 1998;31(2):159-170. doi: https://doi.org/10.1006/appe.1998.0164el Ati J, Beji C, Danguir J. Increased fat oxidation during Ramadan fasting in healthy women: an adaptative mechanism for body-weight maintenance. Am J Clin Nutr. 1995;62(2):302-307. doi: https://doi.org/10.1093/ajcn/62.2.302el Ati J, Beji C, Danguir J. Increased fat oxidation during Ramadan fasting in healthy women: an adaptative mechanism for body-weight maintenance. Am J Clin Nutr. 1995;62(2):302-307. doi: https://doi.org/10.1093/ajcn/62.2.302Lessan N, Hannoun Z, Hasan H, et al. Glucose excursions and glycaemic control during Ramadan fasting in diabetic patients: insights from continuous glucose monitoring (CGM). Diabetes Metab. 2015;41(1):28-36. doi: https://doi.org/10.1016/j.diabet.2014.11.004Lessan N, Hannoun Z, Hasan H, et al. Glucose excursions and glycaemic control during Ramadan fasting in diabetic patients: insights from continuous glucose monitoring (CGM). Diabetes Metab. 2015;41(1):28-36. doi: https://doi.org/10.1016/j.diabet.2014.11.004Williams Textbook of Endocrinology — 14th Edition [cited 13.09.2022]. Available from: https://www.elsevier.com/books/williams-textbook-of-endocrinology/melmed/978-0-323-55596-8Williams Textbook of Endocrinology — 14th Edition [cited 13.09.2022]. Available from: https://www.elsevier.com/books/williams-textbook-of-endocrinology/melmed/978-0-323-55596-8Karamat MA, Syed A, Hanif W. Review of diabetes management and guidelines during Ramadan. J R Soc Med. 2010;103(4):139-147. doi: https://doi.org/10.1258/jrsm.2010.090254Karamat MA, Syed A, Hanif W. Review of diabetes management and guidelines during Ramadan. J R Soc Med. 2010;103(4):139-147. doi: https://doi.org/10.1258/jrsm.2010.090254Ahmedani MY, Alvi SFD, Haque MSU, et al. Implementation of Ramadan-specific diabetes management recommendations: a multi-centered prospective study from Pakistan. J Diabetes Metab Disord. 2014;13(1):37. doi: https://doi.org/10.1186/2251-6581-13-37Ahmedani MY, Alvi SFD, Haque MSU, et al. Implementation of Ramadan-specific diabetes management recommendations: a multi-centered prospective study from Pakistan. J Diabetes Metab Disord. 2014;13(1):37. doi: https://doi.org/10.1186/2251-6581-13-37Hassanein M, Afandi B, Yakoob Ahmedani M, et al. Diabetes and Ramadan: Practical guidelines 2021. Diabetes Res Clin Pract. 2022;185(1):109185. doi: https://doi.org/10.1016/j.diabres.2021.109185Hassanein M, Afandi B, Yakoob Ahmedani M, et al. Diabetes and Ramadan: Practical guidelines 2021. Diabetes Res Clin Pract. 2022;185(1):109185. doi: https://doi.org/10.1016/j.diabres.2021.109185Abdelgadir EIE, Hafidh K. Comparison of Incidences, hospital stay and precipitating factors of diabetic ketoacidosis in Ramadan and the following month in three major hospitals in United Arab Emirates. A prospective observational study. J Diabetes Metab. 2016;6(3):109185. doi: https://doi.org/10.4172/2155-6156.1000514Abdelgadir EIE, Hafidh K. Comparison of Incidences, hospital stay and precipitating factors of diabetic ketoacidosis in Ramadan and the following month in three major hospitals in United Arab Emirates. A prospective observational study. J Diabetes Metab. 2016;6(3):109185. doi: https://doi.org/10.4172/2155-6156.1000514Saadatnia M, Zare M, Fatehi F, et al. The effect of fasting on cerebral venous and dural sinus thrombosis. Neurol Res. 2009;31(8):794-798. doi: https://doi.org/10.1179/016164109X12445505689481Saadatnia M, Zare M, Fatehi F, et al. The effect of fasting on cerebral venous and dural sinus thrombosis. Neurol Res. 2009;31(8):794-798. doi: https://doi.org/10.1179/016164109X12445505689481Spiegel K, Leproult R, Van Cauter E. Impact of sleep debt on metabolic and endocrine function. Lancet Lond Engl. 1999;354(9188):1435-1439. doi: https://doi.org/10.1016/S0140-6736(99)01376-8Spiegel K, Leproult R, Van Cauter E. Impact of sleep debt on metabolic and endocrine function. Lancet Lond Engl. 1999;354(9188):1435-1439. doi: https://doi.org/10.1016/S0140-6736(99)01376-8Upala S, Sanguankeo A, Congrete S, et al. Sleep duration and insulin resistance in individuals without diabetes mellitus: A systematic review and meta-analysis. Diabetes Res Clin Pract. 2015;109(3):e11-12. doi: https://doi.org/10.1016/j.diabres.2015.06.003Upala S, Sanguankeo A, Congrete S, et al. Sleep duration and insulin resistance in individuals without diabetes mellitus: A systematic review and meta-analysis. Diabetes Res Clin Pract. 2015;109(3):e11-12. doi: https://doi.org/10.1016/j.diabres.2015.06.003Rao MN, Neylan TC, Grunfeld C, et al. Subchronic sleep restriction causes tissue-specific insulin resistance. J Clin Endocrinol Metab. 2015;100(4):1664-1671. doi: https://doi.org/10.1210/jc.2014-3911Rao MN, Neylan TC, Grunfeld C, et al. Subchronic sleep restriction causes tissue-specific insulin resistance. J Clin Endocrinol Metab. 2015;100(4):1664-1671. doi: https://doi.org/10.1210/jc.2014-3911Bravis V, Hui E, Salih S, et al. Ramadan Education and Awareness in Diabetes (READ) programme for Muslims with Type 2 diabetes who fast during Ramadan. Diabet Med. 2010;27(3):327-331. doi: https://doi.org/10.1111/j.1464-5491.2010.02948.xBravis V, Hui E, Salih S, et al. Ramadan Education and Awareness in Diabetes (READ) programme for Muslims with Type 2 diabetes who fast during Ramadan. Diabet Med. 2010;27(3):327-331. doi: https://doi.org/10.1111/j.1464-5491.2010.02948.xAhmedani MY, Haque MS, Basit A, et al. Ramadan Prospective Diabetes Study: the role of drug dosage and timing alteration, active glucose monitoring and patient education. Diabet Med J Br Diabet Assoc. 2012;29(6):709-715. doi: https://doi.org/10.1111/j.1464-5491.2011.03563.xAhmedani MY, Haque MS, Basit A, et al. Ramadan Prospective Diabetes Study: the role of drug dosage and timing alteration, active glucose monitoring and patient education. Diabet Med J Br Diabet Assoc. 2012;29(6):709-715. doi: https://doi.org/10.1111/j.1464-5491.2011.03563.xOlczuk D, Priefer R. A history of continuous glucose monitors (CGMs) in self-monitoring of diabetes mellitus. Diabetes Metab Syndr. 2018;12(2):181-187. doi: https://doi.org/10.1016/j.dsx.2017.09.005Olczuk D, Priefer R. A history of continuous glucose monitors (CGMs) in self-monitoring of diabetes mellitus. Diabetes Metab Syndr. 2018;12(2):181-187. doi: https://doi.org/10.1016/j.dsx.2017.09.005Benaji B, Mounib N, Roky R, et al. Diabetes and Ramadan: review of the literature. Diabetes Res Clin Pract. 2006;73(2):117-125. doi: https://doi.org/10.1016/j.diabres.2005.10.028Benaji B, Mounib N, Roky R, et al. Diabetes and Ramadan: review of the literature. Diabetes Res Clin Pract. 2006;73(2):117-125. doi: https://doi.org/10.1016/j.diabres.2005.10.028Nutrition issues [Internet]. [cited 15.05.2022]. Available from: http://www.daralliance.org/daralliance/en/dr/nutrition-issues.htmlNutrition issues [Internet]. [cited 15.05.2022]. Available from: http://www.daralliance.org/daralliance/en/dr/nutrition-issues.htmlShaltout I, Zakaria A, Abdelwahab AM, et al. Culturally based pre-Ramadan education increased benefits and reduced hazards of Ramadan fasting for type 2 diabetic patients. J Diabetes Metab Disord. 2020;19(1):179-186. doi: https://doi.org/10.1007/s40200-020-00489-1Shaltout I, Zakaria A, Abdelwahab AM, et al. Culturally based pre-Ramadan education increased benefits and reduced hazards of Ramadan fasting for type 2 diabetic patients. J Diabetes Metab Disord. 2020;19(1):179-186. doi: https://doi.org/10.1007/s40200-020-00489-1Trabelsi K, Chtourou H. Teaching physical education during Ramadan observance: Practical recommendations. Int J Sport Stud Health. 2019;In Press. doi: https://doi.org/10.5812/intjssh.88013Trabelsi K, Chtourou H. Teaching physical education during Ramadan observance: Practical recommendations. Int J Sport Stud Health. 2019;In Press. doi: https://doi.org/10.5812/intjssh.88013Дедов И.И., Шестакова М.В., Майоров А.Ю., и др. Алгоритмы специализированной медицинской помощи больным сахарным диабетом (10-й выпуск) // Сахарный диабет. — 2021. — Т. 24. — №S1. — С.1-235. doi: https://doi.org/10.14341/DM12802Dedov II, Shestakova MV, Mayorov AYu et al. Standards of specialized diabetes care. Diabetes Mellitus. 2021;24(S1):1-235 (In Russ.). doi: https://doi.org/10.14341/DM12802Papanas N, Katsiki N, Hatzitolios AI, et al. Pioglitazone: a valuable component of combination therapy for type 2 diabetes mellitus. Expert Opin Pharmacother. 2011;12(10):1457-1461. doi: https://doi.org/10.1517/14656566.2011.568477Papanas N, Katsiki N, Hatzitolios AI, et al. Pioglitazone: a valuable component of combination therapy for type 2 diabetes mellitus. Expert Opin Pharmacother. 2011;12(10):1457-1461. doi: https://doi.org/10.1517/14656566.2011.568477Vasan S, Thomas N, Bharani, et al. A double-blind, randomized, multicenter study evaluating the effects of pioglitazone in fasting Muslim subjects during Ramadan. Int J Diabetes Dev Ctries. 2006;26(2):70. doi: https://doi.org/10.4103/0973-3930.28276Vasan S, Thomas N, Bharani, et al. A double-blind, randomized, multicenter study evaluating the effects of pioglitazone in fasting Muslim subjects during Ramadan. Int J Diabetes Dev Ctries. 2006;26(2):70. doi: https://doi.org/10.4103/0973-3930.28276Lv W, Wang X, Xu Q, et al. Mechanisms and characteristics of sulfonylureas and glinides. Curr Top Med Chem. 2020;20(1):37-56. doi: https://doi.org/10.2174/1568026620666191224141617Lv W, Wang X, Xu Q, et al. Mechanisms and characteristics of sulfonylureas and glinides. Curr Top Med Chem. 2020;20(1):37-56. doi: https://doi.org/10.2174/1568026620666191224141617Bakiner O, Ertorer ME, Bozkirli E, et al. Repaglinide plus single-dose insulin glargine: a safe regimen for low-risk type 2 diabetic patients who insist on fasting in Ramadan. Acta Diabetol. 2009;46(1):63-65. doi: https://doi.org/10.1007/s00592-008-0062-7Bakiner O, Ertorer ME, Bozkirli E, et al. Repaglinide plus single-dose insulin glargine: a safe regimen for low-risk type 2 diabetic patients who insist on fasting in Ramadan. Acta Diabetol. 2009;46(1):63-65. doi: https://doi.org/10.1007/s00592-008-0062-7Sari R, Balci MK, Akbas SH, et al. The effects of diet, sulfonylurea, and Repaglinide therapy on clinical and metabolic parameters in type 2 diabetic patients during Ramadan. Endocr Res. 2004;30(2):169-177. doi: https://doi.org/10.1081/erc-200027375Sari R, Balci MK, Akbas SH, et al. The effects of diet, sulfonylurea, and Repaglinide therapy on clinical and metabolic parameters in type 2 diabetic patients during Ramadan. Endocr Res. 2004;30(2):169-177. doi: https://doi.org/10.1081/erc-200027375Cesur M, Corapcioglu D, Gursoy A, et al. A comparison of glycemic effects of glimepiride, repaglinide, and insulin glargine in type 2 diabetes mellitus during Ramadan fasting. Diabetes Res Clin Pract. 2007;75(2):141-147. doi: https://doi.org/10.1016/j.diabres.2006.05.012Cesur M, Corapcioglu D, Gursoy A, et al. A comparison of glycemic effects of glimepiride, repaglinide, and insulin glargine in type 2 diabetes mellitus during Ramadan fasting. Diabetes Res Clin Pract. 2007;75(2):141-147. doi: https://doi.org/10.1016/j.diabres.2006.05.012Amori RE, Lau J, Pittas AG. Efficacy and safety of incretin therapy in type 2 diabetes: systematic review and meta-analysis. JAMA. 2007;298(2):194-206. doi: https://doi.org/10.1001/jama.298.2.194Amori RE, Lau J, Pittas AG. Efficacy and safety of incretin therapy in type 2 diabetes: systematic review and meta-analysis. JAMA. 2007;298(2):194-206. doi: https://doi.org/10.1001/jama.298.2.194Brady EM, Davies MJ, Gray LJ, et al. A randomized controlled trial comparing the GLP-1 receptor agonist liraglutide to a sulphonylurea as add on to metformin in patients with established type 2 diabetes during Ramadan: the Treat 4 Ramadan Trial. Diabetes Obes Metab. 2014;16(6):527-536. doi: https://doi.org/10.1111/dom.12249Brady EM, Davies MJ, Gray LJ, et al. A randomized controlled trial comparing the GLP-1 receptor agonist liraglutide to a sulphonylurea as add on to metformin in patients with established type 2 diabetes during Ramadan: the Treat 4 Ramadan Trial. Diabetes Obes Metab. 2014;16(6):527-536. doi: https://doi.org/10.1111/dom.12249Azar ST, Echtay A, Wan Bebakar WM, et al. Efficacy and safety of liraglutide compared to sulphonylurea during Ramadan in patients with type 2 diabetes (LIRA-Ramadan): a randomized trial. Diabetes Obes Metab. 2016;18(10):1025-1033. doi: https://doi.org/10.1111/dom.12733Azar ST, Echtay A, Wan Bebakar WM, et al. Efficacy and safety of liraglutide compared to sulphonylurea during Ramadan in patients with type 2 diabetes (LIRA-Ramadan): a randomized trial. Diabetes Obes Metab. 2016;18(10):1025-1033. doi: https://doi.org/10.1111/dom.12733Hassanein MM, Sahay R, Hafidh K, et al. Safety of lixisenatide versus sulfonylurea added to basal insulin treatment in people with type 2 diabetes mellitus who elect to fast during Ramadan (LixiRam): An international, randomized, open-label trial. Diabetes Res Clin Pract. 2019;150(2):331-341. doi: https://doi.org/10.1016/j.diabres.2019.01.035Hassanein MM, Sahay R, Hafidh K, et al. Safety of lixisenatide versus sulfonylurea added to basal insulin treatment in people with type 2 diabetes mellitus who elect to fast during Ramadan (LixiRam): An international, randomized, open-label trial. Diabetes Res Clin Pract. 2019;150(2):331-341. doi: https://doi.org/10.1016/j.diabres.2019.01.035Lee SWH, Lee JY, Tan CSS, et al. Strategies to make Ramadan fasting safer in type 2 diabetics: A systematic review and network meta-analysis of randomized controlled trials and observational studies. Medicine (Baltimore). 2016;95(2):e2457. doi: https://doi.org/10.1097/MD.0000000000002457Lee SWH, Lee JY, Tan CSS, et al. Strategies to make Ramadan fasting safer in type 2 diabetics: A systematic review and network meta-analysis of randomized controlled trials and observational studies. Medicine (Baltimore). 2016;95(2):e2457. doi: https://doi.org/10.1097/MD.0000000000002457Loh HH, Yee A, Loh HS, et al. Comparative studies of dipeptidyl peptidase 4 inhibitor vs sulphonylurea among Muslim Type 2 diabetes patients who fast in the month of Ramadan: A systematic review and meta-analysis. Prim Care Diabetes. 2016;10(3):210-219. doi: https://doi.org/10.1016/j.pcd.2015.09.001Loh HH, Yee A, Loh HS, et al. Comparative studies of dipeptidyl peptidase 4 inhibitor vs sulphonylurea among Muslim Type 2 diabetes patients who fast in the month of Ramadan: A systematic review and meta-analysis. Prim Care Diabetes. 2016;10(3):210-219. doi: https://doi.org/10.1016/j.pcd.2015.09.001Niswender KD. Basal insulin: physiology, pharmacology, and clinical implications. Postgrad Med. 2011;123(4):17-26. doi: https://doi.org/10.3810/pgm.2011.07.2300Niswender KD. Basal insulin: physiology, pharmacology, and clinical implications. Postgrad Med. 2011;123(4):17-26. doi: https://doi.org/10.3810/pgm.2011.07.2300Hassanein M, Buyukbese MA, Malek R, et al. Real-world safety and effectiveness of insulin glargine 300 U/mL in participants with type 2 diabetes who fast during Ramadan: The observational ORION study. Diabetes Res Clin Pract. 2020;166(2):108189. doi: https://doi.org/10.1016/j.diabres.2020.108189Hassanein M, Buyukbese MA, Malek R, et al. Real-world safety and effectiveness of insulin glargine 300 U/mL in participants with type 2 diabetes who fast during Ramadan: The observational ORION study. Diabetes Res Clin Pract. 2020;166(2):108189. doi: https://doi.org/10.1016/j.diabres.2020.108189Pathan F, Latif ZA, Sahay RK, et al. Update to South Asian consensus guideline: Use of newer insulins in diabetes during Ramadan Revised Guidelines on the use of insulin in Ramadan. J Pak Med Assoc. 2016;66(6):777-778.Pathan F, Latif ZA, Sahay RK, et al. Update to South Asian consensus guideline: Use of newer insulins in diabetes during Ramadan Revised Guidelines on the use of insulin in Ramadan. J Pak Med Assoc. 2016;66(6):777-778.Hassanein M, Echtay AS, Malek R, et al. Original paper: Efficacy and safety analysis of insulin degludec/insulin aspart compared with biphasic insulin aspart 30: A phase 3, multicentre, international, open-label, randomised, treat-to-target trial in patients with type 2 diabetes fasting during . Diabetes Res Clin Pract. 2018;(135):218-226. doi: https://doi.org/10.1016/j.diabres.2017.11.027Hassanein M, Echtay AS, Malek R, et al. Original paper: Efficacy and safety analysis of insulin degludec/insulin aspart compared with biphasic insulin aspart 30: A phase 3, multicentre, international, open-label, randomised, treat-to-target trial in patients with type 2 diabetes fasting during . Diabetes Res Clin Pract. 2018;(135):218-226. doi: https://doi.org/10.1016/j.diabres.2017.11.027Filippatos TD, Liontos A, Papakitsou I, et al. SGLT2 inhibitors and cardioprotection: a matter of debate and multiple hypotheses. Postgrad Med. 2019;131(2):82-88. doi: https://doi.org/10.1080/00325481.2019.1581971Filippatos TD, Liontos A, Papakitsou I, et al. SGLT2 inhibitors and cardioprotection: a matter of debate and multiple hypotheses. Postgrad Med. 2019;131(2):82-88. doi: https://doi.org/10.1080/00325481.2019.1581971Wan Seman WJ, Kori N, Rajoo S, et al. Switching from sulphonylurea to a sodium-glucose cotransporter2 inhibitor in the fasting month of Ramadan is associated with a reduction in hypoglycaemia. Diabetes Obes Metab. 2016;18(6):628-632. doi: https://doi.org/10.1111/dom.12649Wan Seman WJ, Kori N, Rajoo S, et al. Switching from sulphonylurea to a sodium-glucose cotransporter2 inhibitor in the fasting month of Ramadan is associated with a reduction in hypoglycaemia. Diabetes Obes Metab. 2016;18(6):628-632. doi: https://doi.org/10.1111/dom.12649ъ

The authors declare that there are no conflicts of interest present.